Form 4: Clover Health CLO Officer Executes Tax Withholding

Chief Legal Officer Karen Soares disposed of 10,161 shares of Clover Health Class A Common Stock to satisfy tax obligations related to RSU vesting.

Summary

• Karen Soares, Chief Legal Officer of Clover Health Investments, Corp., reported the disposition of 10,161 shares of Class A Common Stock.
• The transaction occurred on April 15, 2026, at a price of $2.04 per share.
• The shares were withheld automatically to cover tax obligations resulting from the vesting of restricted stock units (RSUs).
• Following this transaction, the reporting person maintains beneficial ownership of 1,572,422 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a mandatory administrative transaction related to tax obligations rather than a market-driven trade.

Positives

• The transaction was a routine administrative action related to tax withholding rather than a discretionary sale of equity.

Negatives

• The transaction represents a reduction in the direct shareholding of a key executive.

Risks

• Continued reliance on RSU vesting schedules for executive compensation may lead to periodic share dispositions for tax purposes.

Future Outlook

The remaining RSUs are scheduled to vest quarterly in equal installments of 6.25% until the final vesting date on October 15, 2028, subject to continued service.

Management Comments

• The transaction represents shares automatically withheld to cover tax obligations on the vesting of RSUs.

Industry Context

StockSavvy.ai notes that this filing is a standard regulatory disclosure for executive equity compensation and does not reflect a change in management sentiment or strategic direction.

Comparison to Industry Standards

• The use of 'sell-to-cover' transactions for tax obligations is a standard practice for equity-based compensation in the healthcare and technology sectors.
• The reporting of these transactions via Form 4 is consistent with SEC requirements for executive officers.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a non-discretionary tax withholding event.

Next Steps

• Continued quarterly vesting of remaining RSUs through October 15, 2028.

Key Dates

Keywords

Clover Health, CLOV, Form 4, Insider Trading, Tax Withholding, Executive Compensation